Single agent gemcitabine (gem) in metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Hugec, V [1 ]
Koulova, L [1 ]
Garino, A [1 ]
Wiernik, PH [1 ]
Dutcher, JP [1 ]
机构：
[1] Our Lady Mercy Med Ctr, Bronx, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：452S / 452S
页数：1
相关论文
共 50 条
  • [21] Efficacy And Toxicity Of Radiotherapy For Oligoprogression Of Metastatic Renal Cell carcinoma (mRCC)
    Dandapani, S. V.
    Salgia, N.
    Dizman, N.
    Zengin, Z. B.
    Hsu, J.
    Pal, S. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E879 - E879
  • [22] Nivolumab in metastatic renal cell carcinoma (mRCC) patients: a real world single-center experience
    Ratta, R.
    Grassi, P.
    Verzoni, E.
    Mennitto, A.
    de Braud, F.
    Procopio, G.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Response of renal lesions in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib - a single center retrospective analysis
    Seidel, C.
    Fenner, M.
    Reuter, C.
    Ivanyi, P.
    Ganser, A.
    Gruenwald, V.
    EJC SUPPLEMENTS, 2009, 7 (02): : 438 - 438
  • [24] Post-axitinib systemic therapy in metastatic renal cell carcinoma (mRCC)
    Haddad, Housam
    Rini, Brian I.
    Jonasch, Eric
    Tannir, Nizar M.
    Dreicer, Robert
    Garcia, Jorge A.
    Wood, Laura S.
    Elson, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Hypertension and cardiotoxicity in metastatic renal cell carcinoma (mRCC) treated with sunitinib (SU)
    Prati, Veronica
    Ortega, Cinzia
    Ballatore, Valentina
    Galizia, Danilo
    Ruatta, Fiorella
    Bonzano, Alessandro
    Aliberti, Sandra
    Grignani, Giovanni
    Aglietta, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Active surveillance (AS) in the management of patients (pts) with metastatic renal cell carcinoma (mRCC).
    Ivanyi, Philipp
    Eggers, Hendik
    Seidel, Christoph Alexander
    Reuter, Christoph
    Ganser, Arnold
    Gruenwald, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Factors affecting treatment trends for metastatic renal cell carcinoma (mRCC) in Australia
    Liow, Elizabeth
    Wong, Shirley
    Weickhardt, Andrew
    Davis, Ian D.
    Shapiro, Jeremy
    Parnis, Francis
    Crumbaker, Megan
    Pranavan, Ganes
    Hocking, Christopher
    Azad, Arun
    Anton, Angelyn
    Spain, Lavinia
    Gibbs, Peter
    Tran, Ben
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 71 - 71
  • [28] Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
    Tracz, Amanda
    Mastri, Michalis
    Lee, Christina R.
    Pili, Roberto
    Ebos, John M. L.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2014, (86):
  • [29] Looking for predictive biomarkers for sunitinib in metastatic renal clear cell carcinoma (mRCC)
    Maroto, P.
    Esteban, E.
    Méndez-Vidal, M. J.
    Fernandez-Parra, E. M.
    Leon, L.
    Perez-Valderrama, B.
    Domenech, M.
    Calderero, V.
    Perez-Gracia, J. L.
    Algaba, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S676 - S676
  • [30] Combination of Gemcitabine and Doxorubicin in Rapidly Progressive Metastatic Renal Cell Carcinoma and/or Sarcomatoid Renal Cell Carcinoma
    Roubaud, G.
    Gross-Goupil, M.
    Wallerand, H.
    de Clermont, H.
    Dilhuydy, M. S.
    Ravaud, A.
    ONCOLOGY, 2011, 80 (3-4) : 214 - 218
12345